Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

NHS


Top 10 Correlated ETFs

NHS


Top 10 Correlated Stocks

NHS


In the News

03:46 04 Oct 2022 NHS

NHS: Rights Offering Quick Notes

NHS's rights offering is now live. The subscription formula has a floor of a -13% discount, at which point one should not subscribe.

04:30 04 Oct 2022 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK, Sept. 30, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock.

04:30 04 Oct 2022 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK , Aug. 31, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on September 30, 2021, has a record date of September 15, 2021 and has an ex-date of September 14, 2021.

12:43 04 Oct 2022 NHS

Evaluating CEFs: NHS Too Expensive For Its Weak Distribution Coverage

The 8.6% yield for NHS looks very attractive if the distribution can be supported. I continue my series looking beyond the yield of a CEF.

04:30 04 Oct 2022 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK, July 30, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on August 31, 2021, has a record date of August 16, 2021 and has an ex-date of August 13, 2021.

05:41 04 Oct 2022 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK, June 30, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on July 30, 2021, has a record date of July 15, 2021 and has an ex-date of July 14, 2021.

04:30 04 Oct 2022 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK, May 28, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on June 30, 2021, has a record date of June 15, 2021 and has an ex-date of June 14, 2021.

04:30 04 Oct 2022 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK, April 30, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on May 28, 2021, has a record date of May 17, 2021 and has an ex-date of May 14, 2021.

12:01 04 Oct 2022 NHS

2 New Closed-End Funds In The Pipeline

Today, I wanted to go over two funds that should tentatively be launching in the future. The fund sponsors have filed with the SEC forms N-2 - this is a file to register new offerings, secondary offerings or anything that involves new shares being created.

05:26 04 Oct 2022 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK, March 31, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on April 30, 2021, has a record date of April 15, 2021 and has an ex-date of April 14, 2021.

Financial details

Company Rating
-
Market Cap
153.52M
Income
29.3M
Revenue
39.15M
Book val./share
12.42
Cash/share
-
Dividend
1.09
Dividend %
13.78%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
5.13
Forward P/E
-
PEG
0.03
P/S
2.23
P/B
0.64
P/C
-
P/FCF
-4.51
Quick Ratio
1.13
Current Ratio
-
Debt / Equity
0.42
LT Debt / Equity
0.42
-
-
EPS (TTM)
3.12
EPS next Y
-
EPS next Q
-
EPS this Y
762.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.5%
Revenue last 5Y
2.71%
Revenue Q/Q
-12.3%
EPS Q/Q
-83.03%
-
-
-
-
SMA20
-10.88%
SMA50
-6.41%
SMA100
-14.76%
Inst Own
0%
Inst Trans
0%
ROA
15%
ROE
25%
ROC
0.17%
Gross Margin
-
Oper. Margin
85%
Profit Margin
75%
Payout
41%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.4-13.22
52W High
-38.62%
52W Low
+14%
RSI
34.21
Rel Volume
0.96
Avg Volume
68.75K
Volume
66.34K
Perf Week
-2.92%
Perf Month
-13.64%
Perf Quarter
-30.49%
Perf Half Y
-31.38%
-
-
-
-
Beta
0.922093
-
-
Volatility
0.11%, 0.45%
Prev Close
1.01%
Price
7.98
Change
-1.12%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-10-31

Metric History 2017-10-312018-10-312019-10-312020-10-31 2021-10-31
Revenue per share
1.32-0.041.310.321.52
Net income per share
1.28-0.081.250.251.38
Operating cash flow per share
0.870.831.081.125.37
Free cash flow per share
0.870.831.081.125.37
Cash per share
0.0100.0400
Book value per share
13.4112.5912.7512.149.33
Tangible book value per share
13.4112.5912.7512.149.33
Share holders equity per share
13.4112.5912.7512.149.33
Interest debt per share
0.110.150.180.111.52
Market cap
229.54M198.51M233.8M218.15M242.15M
Enterprise value
229.42M198.5M233.05M218.13M271.18M
P/E ratio
9.14-130.059.6446.999.04
Price to sales ratio
8.89-237.819.1735.968.21
POCF ratio
13.512.411.1610.312.32
PFCF ratio
13.512.411.1610.312.32
P/B Ratio
0.870.820.940.951.34
PTB ratio
0.870.820.940.951.34
EV to sales
8.89-237.799.1435.959.19
Enterprise value over EBITDA
8.42138.948.4232.329.96
EV to operating cash flow
13.4912.411.1210.312.6
EV to free cash flow
13.4912.411.1210.312.6
Earnings yield
0.11-0.010.10.020.11
Free cash flow yield
0.070.080.090.10.43
Debt to equity
00000.16
Debt to assets
0.330.360.350.360.38
Net debt to EBITDA
0-0.01-0.0301.07
Current ratio
00000
Interest coverage
00000
Income quality
0.68-10.490.864.563.89
Dividend Yield
0.080.080.080.10.07
Payout ratio
0.71-10.550.754.570.61
Sales general and administrative to revenue
0.03-0.790.050.230.03
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
19.684.7318.938.1917.02
ROIC
00000
Return on tangible assets
0.0600.060.010.09
Graham Net
-6.42-6.61-6.53-6.69-5.58
Working capital
00000
Tangible asset value
00000
Net current asset value
00000
Invested capital
00000.16
Average receivables
6.87M7.52M8.43M5.8M4.97M
Average payables
4.13M4.84M6.14M2.03M4.14M
Average inventory
00000
Days sales outstanding
112.31-4.04K158.17349.0151.23
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
3.25-0.092.311.057.12
Payables turnover
00000
Inventory turnover
00000
ROE
0.1-0.010.10.020.15
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2010-06-30 for Q1

Metric History 2008-06-302008-12-312009-06-302009-12-31 2010-06-30
Revenue per share
0.90.820.780.990.87
Net income per share
-0.08-4.143.543.170.54
Operating cash flow per share
-0.24-4.251.590.760.63
Free cash flow per share
-0.24-4.251.590.760.63
Cash per share
0.050.0300.010
Book value per share
12.337.4210.1412.5412.42
Tangible book value per share
12.337.4210.1412.5412.42
Share holders equity per share
12.337.4210.1412.5412.42
Interest debt per share
7.564.775.475.735.59
Market cap
137.99M78.18M101.69M131.8M142.76M
Enterprise value
230M136.2M162.07M194.89M204.45M
P/E ratio
-36.07-0.390.650.946.01
Price to sales ratio
12.487.8111.7712.0714.91
POCF ratio
-47.16-1.55.8115.7420.7
PFCF ratio
-47.16-1.55.8115.7420.7
P/B Ratio
0.910.860.910.951.04
PTB ratio
0.910.860.910.951.04
EV to sales
20.813.618.7517.8521.35
Enterprise value over EBITDA
-240.51-2.694.155.5734.41
EV to operating cash flow
-78.61-2.629.2723.2729.65
EV to free cash flow
-78.61-2.629.2723.2729.65
Earnings yield
-0.01-0.650.380.270.04
Free cash flow yield
-0.02-0.670.170.060.05
Debt to equity
0.60.640.110.420.42
Debt to assets
0.410.420.390.320.32
Net debt to EBITDA
-96.21-1.141.551.810.38
Current ratio
00000
Interest coverage
00000
Income quality
3.061.030.450.241.16
Dividend Yield
0.060.10.060.060.05
Payout ratio
-8.46-0.160.160.241.18
Sales general and administrative to revenue
0.110.110.10.090.12
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
4.6526.2828.4229.9212.27
ROIC
0.040.060.060.050.04
Return on tangible assets
0-0.330.210.170.03
Graham Net
-8.31-5-6.04-5.68-5.36
Working capital
00000
Tangible asset value
00000
Net current asset value
00000
Invested capital
0.610.640.540.460.45
Average receivables
4.61M3.76M5.79M3.59M5.09M
Average payables
00000
Average inventory
00000
Days sales outstanding
45.8535.483.2329.5661.92
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
1.962.541.083.041.45
Payables turnover
00000
Inventory turnover
00000
ROE
-0.01-0.560.350.250.04
Capex per share
00000

Frequently Asked Questions

What is Neuberger Berman High Yield Strategies Fund Inc. stock symbol ?

Neuberger Berman High Yield Strategies Fund Inc. is a US stock , located in New york city of New york and trading under the symbol NHS

What is Neuberger Berman High Yield Strategies Fund Inc. stock quote today ?

Neuberger Berman High Yield Strategies Fund Inc. stock price is $7.98 today.

Is Neuberger Berman High Yield Strategies Fund Inc. stock public?

Yes, Neuberger Berman High Yield Strategies Fund Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap